Pillstats
Rx only · Capsule, Extended Release · Oral

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate

Amphetamine Aspartate Monohydrate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US69 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers11 labelers
Packages69
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 52 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.333$0.665$0.998$1.33Dec 2025Mar 2026Jun 2026
$1.127
Latest avg · Jun 17, 2026
+1%
Since Dec 17, 2025
8
Active US suppliers
33%
Top-2 supplier share*

Who makes it8 active · 3 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager11SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown6SUPPLYING
Camber Pharmaceuticals, Inc.unknown6SUPPLYING
Rhodes Pharmaceuticals LLCunknown6SUPPLYING
ANI Pharmaceuticals, Inc.unknown6SUPPLYING
Elite Laboratories, Incunknown6SUPPLYING
Granules Pharmaceuticals Incunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown4SUPPLYING
Sandoz Incunknown6EXITED 2027
Burel Pharmaceuticals, LLCunknown6EXITED 2028
Prasco Laboratoriesunknown6EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.